NDC 83222-0200 – Lenmeldy

Atidarsagene Autotemcel 11800000 1/1 · Suspension · Intravenous

Cellular Therapy

Product NDC83222-0200

Product details

Brand name
Lenmeldy
Generic name
Atidarsagene autotemcel
Labeler
Orchard Therapeutics (Europe) Ltd
Dosage form
Suspension
Route
Intravenous
Marketing category
BLA · BLA125758
Marketed since
April 26, 2024
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Lenmeldy →

Package NDC codes (1)

Package NDCDescriptionSince
83222-0200-11 SUSPENSION in 1 BAG (83222-0200-1)Apr 26, 2024